HU; Shaojing
Patent Applications and Registrations
Patent applications and USPTO patent grants for HU; Shaojing.The latest application filed is for "tricyclic compounds".
Company Profile
5.20.33
- HU; Shaojing - Beijing CN
- Hu; Shaojing - Hamden CT
Patent Activity
| Patent | Date |
|---|---|
| Tricyclic Compounds App 20220119390 - FANG; Haiquan ; et al. | 2022-04-21 |
| Tricyclic Compounds App 20210179617 - FANG; Haiquan ; et al. | 2021-06-17 |
| Heterocyclic derivatives useful as SHP2 inhibitors Grant 10,988,466 - Ma , et al. April 27, 2 | 2021-04-27 |
| Novel Heterocyclic Derivatives Useful As Shp2 Inhibitors App 20200392128 - Ma; Cunbo ; et al. | 2020-12-17 |
| Crystalline form of fused pyridine derivative's maleate and uses thereof Grant 10,577,364 - Hu , et al. | 2020-03-03 |
| Icotinib-containing Topical Skin Pharmaceutical Compositions And Use Thereof App 20190321369 - Wang; Yinxiang ; et al. | 2019-10-24 |
| Protein tyrosine kinase modulators and methods of use Grant 10,059,688 - Hu , et al. August 28, 2 | 2018-08-28 |
| Crystalline Form Of Fused Pyridine Derivative's Maleate And Uses Thereof App 20180186788 - HU; Shaojing ; et al. | 2018-07-05 |
| Protein Tyrosine Kinase Modulators And Methods Of Use App 20180009782 - HU; Shaojing ; et al. | 2018-01-11 |
| Protein tyrosine kinase modulators and methods of use Grant 9,783,524 - Hu , et al. October 10, 2 | 2017-10-10 |
| Polymorphic forms of icotinib phosphate and uses thereof Grant 9,688,687 - Hu , et al. June 27, 2 | 2017-06-27 |
| Fused pyridine derivatives useful as c-Met tyrosine kinase inhibitors Grant 9,617,257 - Hu , et al. April 11, 2 | 2017-04-11 |
| Polymorphic forms of icotinib and uses thereof Grant 9,611,272 - Hu , et al. April 4, 2 | 2017-04-04 |
| Polymorphic forms of icotinib maleate and uses thereof Grant 9,505,774 - Hu , et al. November 29, 2 | 2016-11-29 |
| Glucagon like peptide analogs, composition, and method of use Grant 9,487,570 - Hu , et al. November 8, 2 | 2016-11-08 |
| Icotinib-containing Topical Skin Pharmaceutical Compositions And Uses Thereof App 20160235757 - WANG; Yinxiang ; et al. | 2016-08-18 |
| New Polymorphic Forms Of Icotinib Phosphate And Uses Thereof App 20160145262 - HU; Shaojing ; et al. | 2016-05-26 |
| Protein Tyrosine Kinase Modulators And Methods Of Use App 20160145237 - Hu; Shaojing ; et al. | 2016-05-26 |
| Polymorphic Forms Of Icotinib Maleate And Uses Thereof App 20160137658 - Hu; Shaojing ; et al. | 2016-05-19 |
| Polymorphic Forms Of Icotinib And Uses Thereof App 20160108055 - Hu; Shaojing ; et al. | 2016-04-21 |
| Substituted fused heterocycles as c-Met tyrosine kinase inhibitors Grant 9,242,991 - Hu , et al. January 26, 2 | 2016-01-26 |
| NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS App 20150315210 - HU; Shaojing ; et al. | 2015-11-05 |
| Glucagon-like peptide-1 analogues and uses thereof Grant 8,951,959 - Wang , et al. February 10, 2 | 2015-02-10 |
| Methods Of Preparing Icotinib And Icotinib Hydrochloride, And Intermediates Thereof App 20140343283 - Hu; Shaojing ; et al. | 2014-11-20 |
| Novel Glucagon Like Peptide Analogs, Composition, and Method of Use App 20130203672 - Hu; Shaojing ; et al. | 2013-08-08 |
| Novel Fused Heterocyclic Derivatives Useful as c-Met Tyrosine Kinase Inhibitors App 20130123286 - Hu; Shaojing ; et al. | 2013-05-16 |
| Glucagon-like Peptide-1 Analogues And Uses Thereof App 20130053304 - Wang; Yinxiang ; et al. | 2013-02-28 |
| Phenyl substituted carboxylic acids Grant 7,524,878 - Whitehouse , et al. April 28, 2 | 2009-04-28 |
| Substituted Carboxylic Acids App 20090082392 - Van Zandt; Michael C. ; et al. | 2009-03-26 |
| Substituted amino carboxylic acids Grant 7,498,356 - Whitehouse , et al. March 3, 2 | 2009-03-03 |
| Phenyl substituted carboxylic acids Grant 7,465,825 - Van Zandt , et al. December 16, 2 | 2008-12-16 |
| Heterocycle Substituted Carboxylic Acids App 20080146574 - Whitehouse; Darren ; et al. | 2008-06-19 |
| Substituted amino carboxylic acids Grant 7,358,248 - Whitehouse , et al. April 15, 2 | 2008-04-15 |
| Substituted carboxylic acids Grant 7,358,364 - Van Zandt , et al. April 15, 2 | 2008-04-15 |
| Heterocycle substituted carboxylic acids Grant 7,329,680 - Whitehouse , et al. February 12, 2 | 2008-02-12 |
| Substituted heteroaryl CB1 antagonists App 20070078135 - Yuan; Jun ; et al. | 2007-04-05 |
| Phenyl substituted carboxylic acids App 20060122257 - Van Zandt; Michael C. ; et al. | 2006-06-08 |
| Substituted amino carboxylic acids App 20060122223 - Whitehouse; Darren ; et al. | 2006-06-08 |
| Heterocycle substituted carboxylic acids App 20060122222 - Whitehouse; Darren ; et al. | 2006-06-08 |
| Substituted phenylalkanoic acids App 20060100251 - Van Zandt; Michael C. ; et al. | 2006-05-11 |
| Substituted carboxylic acids App 20060094747 - Van Zandt; Michael C. ; et al. | 2006-05-04 |
| Substituted heteroaryls App 20050009817 - Savoy, Jennifer ; et al. | 2005-01-13 |
| Heterocycle substituted carboxylic acids App 20050004114 - Whitehouse, Darren ; et al. | 2005-01-06 |
| Phenyl substituted carboxylic acids App 20050004369 - Whitehouse, Darren ; et al. | 2005-01-06 |
| Substituted amino carboxylic acids App 20040266789 - Whitehouse, Darren ; et al. | 2004-12-30 |
| Substituted carboxylic acids App 20040266788 - Van Zandt, Michael C. ; et al. | 2004-12-30 |
| Substituted phenylalkanoic acids for the treatment of diabetes App 20040248937 - Van Zandt, Michael C. ; et al. | 2004-12-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 